You are here

Study Evaluating Sirolimus in Kidney Transplant Recipients in India

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Bangalore, Karnataka, 566 006 India
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Kidney Failure, Graft vs Host Disease
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
13 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Patients in End Stage Renal Disease who are above 13 years of age and weigh more than
40 kilograms.

- Patients scheduled to receive a kidney from a cadaveric donor, from a living unrelated
donor or from a living related donor.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Evidence of major infections at the time of sirolimus administration

- Use of any investigational drug or treatment up to 4 weeks prior to enrolling in the
study and during the treatment phase.

- Females who are pregnant, breast feeding or in reproductive age group and not using a
medically acceptable form of contraception

NCT00195481
Pfizer
Completed
Study Evaluating Sirolimus in Kidney Transplant Recipients in India

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now